U.S. stock indices are poised for an upward movement as Treasury yields decline, largely due to tariff relief measures. This shift in the market is accompanied by various developments in individual stocks that are influencing investor sentiment.

Apple shares have seen a decrease of 1.3% following a downgrade, with the price target adjusted from $211.84 to $200.75. This change is attributed to disappointing iPhone sales, which have raised concerns among investors.

In contrast, Walgreens Boots Alliance is facing a significant challenge, experiencing a 7% decline in its stock price after a lawsuit was filed against the company. The lawsuit accuses Walgreens of contributing to the opioid crisis, which has led to increased scrutiny.

On a more positive note, Moderna’s stock has surged by nearly 5% after the company received a $590 million award from the federal government. This funding is aimed at accelerating the development of a bird flu vaccine, highlighting the ongoing efforts in public health.

Additionally, Intel shares have climbed over 4% amid speculation regarding a potential takeover of the struggling chipmaker, indicating a shift in market dynamics and investor interest.

📎 Related coverage from: marketwatch.com